[go: up one dir, main page]

Lacroix et al., 2010 - Google Patents

Magnetic nanoparticles as both imaging probes and therapeutic agents

Lacroix et al., 2010

Document ID
8098308227978330819
Author
Lacroix L
Ho D
Sun S
Publication year
Publication venue
Current Topics in Medicinal Chemistry

External Links

Snippet

Magnetic nanoparticles (MNPs) have been explored extensively as contrast agents for magnetic resonance imaging (MRI) or as heating agents for magnetic fluid hyperthermia (MFH)[1]. To achieve optimum operation conditions in MRI and MFH, these NPs should have …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb

Similar Documents

Publication Publication Date Title
Lacroix et al. Magnetic nanoparticles as both imaging probes and therapeutic agents
Kowalik et al. Yttrium-doped iron oxide nanoparticles for magnetic hyperthermia applications
Ho et al. Monodisperse magnetic nanoparticles for theranostic applications
Shakeri-Zadeh et al. Imaging-guided precision hyperthermia with magnetic nanoparticles
Xie et al. Shape-, size-and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics
Hugounenq et al. Iron oxide monocrystalline nanoflowers for highly efficient magnetic hyperthermia
Yang et al. Multifunctional self-assembled supernanoparticles for deep-tissue bimodal imaging and amplified dual-mode heating treatment
Mazario et al. Magnetic hyperthermia properties of electrosynthesized cobalt ferrite nanoparticles
Salunkhe et al. Magnetic hyperthermia with magnetic nanoparticles: a status review
Lartigue et al. Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties
Lee et al. Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy
Yang et al. The roles of morphology on the relaxation rates of magnetic nanoparticles
Lartigue et al. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents
Issa et al. Magnetic nanoparticles: surface effects and properties related to biomedicine applications
De la Presa et al. Study of heating efficiency as a function of concentration, size, and applied field in γ-Fe2O3 nanoparticles
De La Presa et al. Particle interactions in liquid magnetic colloids by zero field cooled measurements: Effects on heating efficiency
Liu et al. Innovative magnetic nanoparticle platform for magnetic resonance imaging and magnetic fluid hyperthermia applications
Lu et al. Hydroxyl–PEG–phosphonic acid-stabilized superparamagnetic manganese oxide-doped iron oxide nanoparticles with synergistic effects for dual-mode MR imaging
Rajan et al. Hydrophobic-to-hydrophilic transition of Fe3O4 nanorods for magnetically induced hyperthermia
Nandwana et al. Exchange coupling in soft magnetic nanostructures and its direct effect on their theranostic properties
Chandunika et al. Magnetic hyperthermia application of MnFe2O4 nanostructures processed through solvents with the varying boiling point
Kyeong et al. Magnetic nanoparticles
Farkaš et al. A perspective on modelling metallic magnetic nanoparticles in biomedicine: From monometals to nanoalloys and ligand-protected particles
Kim Controlled magnetic properties of iron oxide-based nanoparticles for smart therapy
Maier et al. Enhancing magnetic hyperthermia efficiency in Pd/fe-oxide hybrid nanoparticles through Mn-Doping